These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10167175)

  • 1. The corporate practice of medicine: a call for action.
    Mars S
    Health Matrix Clevel; 1997; 7(1):241-300. PubMed ID: 10167175
    [No Abstract]   [Full Text] [Related]  

  • 2. The corporate practice of medicine doctrine must go.
    Dowell MA
    Healthspan; 1994 Nov; 11(10):7-11. PubMed ID: 10138838
    [No Abstract]   [Full Text] [Related]  

  • 3. The business of medicine: problems with the corporate practice doctrine.
    Rosoff AJ
    Spec Law Dig Health Care (Mon); 1988 Aug; 9(14):7-25. PubMed ID: 10288326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corporate practice of medicine: last stand or final downfall?
    Parker J
    J Health Hosp Law; 1996; 29(3):160-73. PubMed ID: 10160033
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of fraud and abuse regulations.
    Mackelvie CF; Handler MS; Sanborn AB
    Healthc Financ Manage; 1992 Oct; 46(10):26-30, 32-3. PubMed ID: 10145687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitrust law and the physician entrepreneur.
    Relman AS
    N Engl J Med; 1985 Oct; 313(14):884-5. PubMed ID: 4033717
    [No Abstract]   [Full Text] [Related]  

  • 7. The Centers for Medicare and Medicaid Services.
    Iglehart JK
    N Engl J Med; 2001 Dec; 345(26):1920-4. PubMed ID: 11756589
    [No Abstract]   [Full Text] [Related]  

  • 8. The white coat syndrome.
    Hirsch WR
    J Oncol Manag; 1998; 7(5):17-8. PubMed ID: 10187172
    [No Abstract]   [Full Text] [Related]  

  • 9. Advisory opinion No. 98-4: what's next?
    Becker S
    Benders Health Care Law Mon; 1998 Jun; ():11-3. PubMed ID: 10181975
    [No Abstract]   [Full Text] [Related]  

  • 10. The corporate practice doctrine: is it still viable?
    Manger JA; Cowell LJ
    Healthspan; 1989 Apr; 6(4):3-10. PubMed ID: 10303451
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitrust enforcement in health care. Ten years after the AMA suit.
    Costilo LB
    N Engl J Med; 1985 Oct; 313(14):901-4. PubMed ID: 4033726
    [No Abstract]   [Full Text] [Related]  

  • 12. The fraud and abuse provisions of the Kassebaum-Kennedy bill.
    Desmarais HR
    Bull Am Coll Surg; 1997 Mar; 82(3):8-13. PubMed ID: 10166194
    [No Abstract]   [Full Text] [Related]  

  • 13. Making sense of the federal sentencing guidelines: how health care corporations can manage risk by adopting corporate compliance programs.
    Radinsky G
    J Health Hosp Law; 1997 Jun; 30(2):113-24. PubMed ID: 10169575
    [No Abstract]   [Full Text] [Related]  

  • 14. "Free choice" as a restraint of trade in American health care delivery and insurance.
    Weller CD
    Spec Law Dig Health Care (Mon); 1985 May; 7(3):5-46. PubMed ID: 10300085
    [No Abstract]   [Full Text] [Related]  

  • 15. Reviewing hospital-physician contracts: reading between the lines.
    Vinson RK; O'Connor MK
    Healthspan; 1990 Mar; 7(3):3-7. PubMed ID: 10104393
    [No Abstract]   [Full Text] [Related]  

  • 16. The corporate practice of medicine doctrine: an anachronism in the modern health care industry.
    Chase-Lubitz JF
    Vanderbilt Law Rev; 1987 Mar; 40(2):445-88. PubMed ID: 11649888
    [No Abstract]   [Full Text] [Related]  

  • 17. It's time to define "Medicare kickback".
    Schorr B
    Physicians Manage; 1988 Jun; 28(6):191-3. PubMed ID: 10302584
    [No Abstract]   [Full Text] [Related]  

  • 18. Hospital/physician contracting and the illegality defense.
    Peregrine MW; Waller AA; O'Dwyer JS
    J Health Hosp Law; 1994 May; 27(5):129-40, 160. PubMed ID: 10137987
    [No Abstract]   [Full Text] [Related]  

  • 19. Independent physicians organizations: are they a solution?
    Kopit WG
    Internist; 1987 Jul; 28(6):12-3, 16. PubMed ID: 10282657
    [No Abstract]   [Full Text] [Related]  

  • 20. OIG advises that marketing/distribution arrangement may violate anti-kickback provision.
    Ramsey RB
    Benders Health Care Law Mon; 1998 May; ():19-22. PubMed ID: 10181979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.